Modulation of GABA-A Receptors in Parkinson Disease-Transdermal Flumazenil Arm

NCT03440112 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Clarithromycin (Not used as of 4/2020)
DRUG: Placebo (Not used as of 4/2020)
DRUG: Transdermal flumazenil (Added 4/2020)
DRUG: Placebo (Added 4/2020)

Sponsor

Nicolaas Bohnen, MD, PhD

Collaborators

[object Object]